Self-assembled nanoparticles based on glycol chitosan bearing 5 beta-cholanic acid for RGD peptide delivery

Authors
Park, JHKwon, SGNam, JOPark, RWChung, HSeo, SBKim, ISKwon, ICJeong, SY
Issue Date
2004-03-24
Publisher
ELSEVIER SCIENCE BV
Citation
JOURNAL OF CONTROLLED RELEASE, v.95, no.3, pp.579 - 588
Abstract
The synthetic peptide bearing Arg-Gly-Asp (RGD) sequence is considered to specifically bind to alpha(v)beta(3) integrin expressed on endothelial cells in the angiogenic blood vessels, which provides a potential to inhibit the tumor growth. As a carrier for the RGD peptide, hydrophobically modified glycol chitosan (HGC) capable of forming nano-sized self-aggregates was prepared by the chemical conjugation of 5beta-cholanic acid to the main backbone of glycol chitosan. The RGD peptide labeled with fluoresein isothiocyanate (FITC-GRGDS) was loaded into self-aggregates in three different conditions: simple mixing, sonication, and solvent evaporation methods. Of different methods applied, solvent evaporation method showed the most promising results for peptide loading, as judged by the yield (>70%) and loading efficiency (>75%). It was found that the presence of FITC-labeled peptides makes the self-aggregates to be compact, possibly due to the role of both hydrophobic FITC and peptides containing carboxylic acids that allow hydrogen bonding and electrostatic interaction with the primary amino groups in the main backbone of glycol chitosan. FITC-labeled peptides were released from self-aggregates in a physiological solution (pH 7.4) for up to 1 day. From the cell adhesion and migration assays, it was demonstrated that FITC labeling of peptides does not significantly deteriorate biological activity of the parent peptide drug (GRGDS). Overall, the self-aggregates loaded with FITC-GRGDS might be useful for monitoring or destroying the angiogenic vessels surrounding the tumor tissue. (C) 2004 Elsevier B.V. All rights reserved.
Keywords
BLOCK-COPOLYMER MICELLES; DRUG-DELIVERY; INTEGRIN ALPHA(V)BETA(3); TUMOR VASCULATURE; ANGIOGENESIS; BETA-IG-H3; IDENTIFICATION; DOXORUBICIN; DERIVATIVES; ADRIAMYCIN; BLOCK-COPOLYMER MICELLES; DRUG-DELIVERY; INTEGRIN ALPHA(V)BETA(3); TUMOR VASCULATURE; ANGIOGENESIS; BETA-IG-H3; IDENTIFICATION; DOXORUBICIN; DERIVATIVES; ADRIAMYCIN; peptide drug delivery; RGD peptide; self-aggregates; glycol chitosan
ISSN
0168-3659
URI
https://pubs.kist.re.kr/handle/201004/137754
DOI
10.1016/j.jconrel.2003.12.020
Appears in Collections:
KIST Article > 2004
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE